)< $&+!C;< &28 <!8D& & E%(;#,;F/.!

"""!! ' &%!"#$ SHV#! $%!$&'!()*+! "! #$%&%'#()*+,-./! "0 --( 12$%&%'#324 5&678 0 --( 12$%&%'#324 5&678 982" E.mail khakipjvak@yahoo.com p.khaki@rvsri.ir=>?@>a>@ <,- + )< $&+!C< &28 <!8D& & E%(#,F/.! I%6"DJH*83"8K L /"-G"-)F&8H*8!2 Q38RFI,FM)7<N&# %O<3P6"&" M)7<N&#!&SHV%!S J!D&5&#&8.I%/F 8 32 4 5& 678 8 5&!&25) V,F N&# U= T#,F [&#[&#J<Y-Z8XRTCCW0 --( 12$%&%'# J P 8 ESLF<N&# "IV\& #]2"Y-[&#J!-./'! " P 8PCR-Z8bla SHV!S_+^[&#SYIJ P Z "1&2,J`a&2D&Z<]&#&8.38I\23TFb<N&# (#/& ]&#&8.38I\2<I%1" &88c2+1&5&.1&2)J a&2#za - < Xd?@W1&)5" # XdA=W1&J & XdA=W1&25FZ < F3"V=\& #]2"!-.g"c 88"OI%XdAfUW<3"V 8bla SHV!SXd@W3"V6#!&1"3h&7 #ESL! &i( bla SHV %!S_+! "81&F 83TFb1"/01 N&# 1"j% bj+!s1"k+<n&# l-! 1"3 <6"-.((DF1" 88V!238m81"n" i-]&#&8.38(%< (-p3tveslf<n&# o1" 2"5&#&8.I&2+1&&T# I q PCR, bla SHV, ESLs,5&#&8.I%/%!*

!5< X ( = )*?$ F/L 7 '$i K$-L$?G E " % $ A= j $ Zg$ ] F.<`9 0 $ F 7!! 4 V Q %!" D 4 E E8 $ AF %5?$G!Lk3+ "j$$?$%& ] F #<9 0 =+ $ I- "8 123 %$0Q Zg$ 70 4 $^ / l!5 & &&$ %8 0 I-?$mn% $ = $ % E %$5 #<T9$0 6 0 p 0 $$ 0 % o?$4c#<x9&$o?f= 0WfY ) 0 %@ ) 0 E % ]8!)$!%&O'$(0-"$/5 $^ + %5 0 $ ) 0 )"$ $qr $0J$rn?$0#$%L@ %$5)0bla SHV )P.(ESL E$0)"$9Z3]!$7&$5 #L@$^0<[,-../0&+ 123/04,56.&+ H= K3 = )"= 0 05 %$5 fy s$ E?"$ 'n %"!& %$5X)?$0#!L@$^0t u+!-%$5u[$%$5tx"$u+! #<6590E$0 $%#!",-./%&'$()"$*+ %/6(0 +0123)450&$4?4%=> $#<9$7&8)$$%5$ A )0 0%!-@ A % 8" 4C!&?$ )$!/ E "?G D EF $JK$-L$MI54 %H3$?$ )-L$ N"@ 0 #$ 7& %!?$ 0 I- 7 O )P Q8R %@ %" )&6/LRM%!&F S$%>0<EF%(9?G- 7@ WXY % 0 V$$ 0 #<UT9& $0 )& ]\ Z[ F E % I- $ 5?G _3 % 0^ % &!&ESLs )" I"! ]S$ Z[ $a?$%b2%#<`90i ^J0$A$ A J0"%"$$04P6$0 %@ % = %@ A $ ]& 'c % ( E % )-L$ a& M J0 %@?$$$$#<d9$7&)00=+ a$$ )?$ 0 % $ 7& %!& I- +a&ctx-m$)0shv,tem 7&N$-@)$$%5$Z3 + 7^0,- O V Q8R I-?$ #<f`9$ Z3 a$$ & ) <+ YYkbF9 $!-J5) 68 K45 0>$ %g$%?$ % $ 7 054 6/L 7J5 0 7h % %! 4

"""!!!"#$%&'(')*+(+(* Salmonlla abrdn 1585 1 Salmonlla arizona 1598,1622 2 Salmonlla ntritidis 1621 3 Salmonlla cholrasuis Salmonlla infantis 1625 1650 4 5 Salmonlla nigria 1666,1667 6 Salmonlla papuana Salmonlla paratyphi A Salmonlla paratyphi Salmonlla paratyphi C Salmonlla paratyphi Salmonlla blgdam Salmonlla bracdrup Salmonlla drby Salmonlla dussldrof Salmonlla gallinarum Salmonlla group Salmonlla group C1 Salmonlla group E4 Salmonlla havana Salmonlla Kntucky Salmonlla Kottbus 1670 1671, 1674, 1676, 1677 1678 1687,1688 1689,1690 1605 1606 1614 1619 1626,1628,1630,1632,1644 1635 1634,1637, 1638, 1639 1643 1645,1647 1651 1652 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Salmonlla Kuilsrivir 1654 23 Salmonlla mlagridis Salmonlla munchn Salmonlla montvido Salmonlla moscow Salmonlla mura Salmonlla typhimurium Salmonlla rcding Salmonlla rostock Salmonlla infantis Salmonlla ntritidis Salmonlla bakongo Salmonlla group C2 Salmonlla sftnbrg Salmonlla poona Salmonlla mbandaka Salmonlla capci 1659,1660 1662 1663 1664 1665 1679 1698 1699 1693-62, 1693-73, 1693-82, 1693-69, 1693-64 1624,1693-59 1693-80 1640 1704 1627,1691 1658 1608 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39

!5< X ( <+ Salmonlla astbourn Salmonlla ntritidis 1620 1623 40 41 Salmonlla arizona 1599 42 Salmonlla birknhad 1604 43 Salmonlla abortus ovis 1592 44 Salmonlla archavalta 1597 45 Salmonlla abortus 1591,1596 46 Salmonlla oraninburg 1669 47 ESL JK 'LMN "#HIG! 9F P+K5Combinatd Disk1KOM!%K P,K//M,K"K#!KQ)KRKS/K,!0 KMKT)R"#%'J "#MN E,!0P+P,WP @PVWU,F "#! %& '()% %$!$."! CLSI,-! *+ 9 8!067543432 ph10/# "? =>2 <, E5D18!0!! CA@4 ) %&!&'($!"# ' Cftazidim 30 g Cfotaxim 30 g Cfapodoxim 30 g,-*+(' Cftazidim 30 g + 10 g of Clavulanic acid Cfotaxim 30 g + 10 g of Clavulanic acid Cfapodoxim 30 g + 10 g of Clavulanic acid %$5k3$lO#<T659L@$^ ELs!L0$$N% L=$v$07J0$70$7&k3 70$=YI>(%6n#& %4% $< &9l="$ w! 0 $q@ 0$@ N #<U659& #0@?/$O$_! $%&'"()*+#!"#! 0' # ESL # /.,-# "# 2 1 )204,56.87&+ 960-.8 p0$bla SHV )P.(PCRK 0 c2$ $O $ 70$ %/g 0

?"""!! Targt gn R blashv Pitout t al. 1998 Hasman t al. 2005 SHV-F 5 -CACTCAAGGATGTATTGTG -3 950 Sanz t al. 2004 SHV-R 5 -TTAGCGTTGCCAGTGCTCG -3 Riano t al. 2006 '4567!"#+,-./01-23*!" #!" 1 30 1 <!"#908 6 53 4 ()2$10%#/"., %78, %789 %8*!, <=7>?@8.* %6 8.* A!, 6 5 4 DE?()C1&%!8 "7A 8 "8 7D!,6% @8()#1$F%# 5(FG">3 =& 608>?@A16& %()&'%#$"! -, ()&'%? '@>= #$"+,* 34/+(**$.!"(/+(**$.!"/+(**$ ' 012 012 012 01792 016875256 AN2# 01?29 018752> 0157929> AM2#<= 017C2 01C72 01CC7929 SAM23,@A7#<= >

!5< X ( <7 01C72 01792 0157929> AMX2#<!, 9 01>8752C 0197>2C 01>C725 TE2#<* 017928 01?29 015875298 CZ2#A&D 5 01762 016C7258 CRO2%!,D C 01792 016875256 CP2#!,<E= 8 017C29 01762 01679259 SXT2&!,, 6 01C72 0167625 GM2#!? 01792 016875256 IPM2FG* 019?28 0187525 01792>5 FM2#H*E 01??2C? OFX2#!,IEJ* > 017C29 017C29 0197>25 PIP2#<*=G 9 019?28 018752? 01>792 CN2#!AD 018752> 01C726 0197>2>8 CF2#AD 5 0197>2> 01C72 01887525 CFM2F!D C 01762 017626 01897>26 CAZ2F&D 8 01762 016C7258 CTX2F!,D 6 01792 01762 0167C25C FEP2FGD? 01792 016875256 CT2F!,KD 01?2C 01>8752C 01792>5 XM2F!,D 0197>2C 0197>2> 01C792? FR2%A&*E > 0197>2? 017C2 01C?296 K2#!, 9 01?2C 016?25> C2LD*<, 017928 0187525 018?25 NA2*'!A 5 017626 01792>5 01>7C2 N2#!M C 01??2C? NFX2#!,<E* 8 0197>2> 01792 01697>255 FF2E<E 6 017C28 01C97>2 CL2#!<, >? %OK>!, 6 C2!,65(0G" 789 %8P 5(C@">3 @8 J.K, 6 L&F H@I -,5(0G"34!, 6 D! M ( )CF1/" CC ()&F1/" 5 3 5(MDR" >N

f"""!! 4N 4/OA* +(**$ $0 N $0 CN > $0 CL T 9 $0 FM U $0 TE 5 $0 AMX C $0 CF 8 $0 GM 6 $0 AMX,FM? $0 FM,FR T $0 CL,CN ` $0 AM,CN > $0 CZ,FM 9 $0 CN,TE K,N,TE 5 CL,CN,CP C CAZ,CL,CN 8 TE,AMX,CZ 6 CN,CF,TE? AM,FR,FM CN,FR,FM CN,CL,FM > FR,FM,N,TE 9 $0U TECNCRO,CF $0U C,FF,NA,PIP 5 $0` CNNACLXM,FM C $0d AM,PIP,FM,CF,CN,TE 8 $0d FR,FM,N,K,SXT,TE C%D5A

6 $0d NA,FF,C,CN,CF,TE >? $0d CL,FR,FM,GM,CF,TE > $0f CL,NA,AM,FR,FM,TE > $0f FR,FM,N,TE,K,AM,,C >> $0X AMX,NA,CFM,AM,FR,FM,CN,TE >9 $0X XM,TE,AM,SAM,K,GM,CF,AMX > $0X FR,TE,AM,SAM,K,C,CN,AMX >5 $0X SAM,CL,NA,FR,FM,CN,TE,CZ >C $0X SAM,CL,NA,FR,FM,CN,TE,AM >8 $0W CF,IPM,CTX,OFX,FM,C,CN,CT,TE >6 $0W CF,IPM,CAZ,CN,CZ,AM,XM,SAM,CFM 9? $0W CF,SXT,K,CRO,FEP,XM,CN,FM,TE 9 $0W AM,AMX,SAM,CL,NA,CN,FR,FM,TE 9 $0Y SAM,XM,AM,FM,AMX,CN,TE,K,CF,GM 9> $0 SAM,AM,XM,FF,CZ,AMX,CFM,CF,CN,FM,TE 99 CZ,AMX,CN,TE,K,SAM,XM,AM,PIP,CL,FM,CF,FR 9 CZ,AMX,CN,TE,K,SAM,XM,AM,PIP,N,C,SXT,GM F&D/+'! 3Q(A+RDPL -*'SI,/"/+'!(!4F!,GD 3,S/+'( @! 4TP*!5< X ( <

U"""!! 78?! W, D 9! 5 3 3!P8 1 78? W,Y ZD%D! 78? 7D! TK,ESLX[%!P8[ 534 ESL %8,!D6D46MQ R,@S834TK,ESL4 7D!(F" UVW,Q TK!P8 17D 5(CX3/4@3G"3 ",F=X<T)RE4U,F RTCC No. C0## C0c' C0&/ C0&' CFcc C0/c "#$ S.arizona S.paratyphi S.havana S.group C2 S.arizona S.paratyphi! Z Z TE,FM,FF,SAM CL TE,K,GM, TE,K,GM,FM,S AM SAM TE CF,CN,CFM,CZ,X M, AMX CN,CAZ XM,AM,CF, AMX XM,AM,CN,CF, AMX XM,AM,CN,CF, AMX,XM,CFM,CA Z CRO,CN,CF ESL ESL C0'& C0#F C02$ C0F& S.birknha d S.cholrasui s S.groupC1 S.kuilsrivir Z Z FM,TE,K,CL,PI P,SAM, FM FR,FM FM CF,CZ,CN,AM,XM f CN - f f f f ATCC >?.8 " d G >8 7^83bla SHV _%(700603 7&6598 %Z #<=&f PCR0>& ][-,^%@, PCR\D6M 0 8 >`ab @? bla SHV _ * d,-uvg-cf'bp[-uvi

!5< X ( <D 0@4Y$WX2 *GRSUV&EA*&*LT"R$WXL 02,KP% @Z /+(*P% %[XE/+(*P% (GI!@<, @Z,(P% D,(P% I\\"\\!E\\\\"\\?G\\ \\0\8%%5II"- #&jq4 %8"*$0$/ K E>$E--4> 7J+ %?$! <## E$@ 9= "(?/ Q )0 45 A a -> $ 8^ o %!- 6$7J0% @$#0&j"($ 0 J$ 4 % >! $?= '+?$ % k3+%"%r^0 J$0&%!?$ R A )0b$-@ %!- %0& %$)0%!/a%%"S &O I+ ^ '+?$ %!- *$ 0 %8$ # D! %Lc % ) Q $ a_!23+ A"0@= Q4 " }nc E>$ 05 0$$ j$ %0$$8/= A"0$70$ J0K3-&05$0>'2 $ $ o 23+ 4 J+ % % $ %" # 0=+ 4C."8&7 \&&$ %@)0 )P+$_^/ A\\ %E 4C"8 7\&8'$()"$?0,-=+% V\F\[4\E\\ \#<9\$ #\$%\L@$\^0)450!n q\o\j$-\%\/g?$07 x $)%$0/'n$"rg y \+%\/g?\$0%\=g#$%lqo'c \"!G\\ A %8" \!O\?\"=?\?\\D6$ 70\$\?\\G \D^? #\"0?\ z$0\\4 $E$'F[ A\ %8"V$(0f7 + %/g?$0?ge0"$i" %\8\"%&_g?$ #\$K$-\L$6\(0-\E0\" A \!\5\ A\ _!S?!{

>"""!! #<U`Ud9\$7\&N$-\@-\Q8\^\[ 0)$= 0V8^%/g0?!{?\+r\n?\$\!%\\[\ %$5) )\$L?\$L%\8\"\ \ %8" %"(&7 +?"=?\"!5?\"L$6\=!LL\ A\ #<f9&70$0)+?"l$ \YYW6\0)\(V%$%/g0 <X9\&E\>$)$\40\=! %$5 < ` `9?G < UT f9?=$%x %\\\\\\"(?\\\!{ < U f9\\\=!$ #0\\ (%/gxrgq8?"lg A\\"=%\\\\ƒ\\Lr\\nl=\\\\$ )+$< U9$rn?$0< U` f9$ #0$0 PCR\!GP4&F %!- IR N"@k3+G!L4&%"0 )\ /S )0%>!=4& \\4E\\\ %-$N"@$@5 #00@ %\/g?\$0%shv)p.( \ %\$5I4\%\\&N$-@< U T9%$5d0 )$-\?$% @$#0%$5E$ E$0[)"$ fu T%%0YYU60$%/g%"0 D <9\0)P?$(0 %$5 $$0\%\$5 T%K= ghldr 0%\$%\/g\<W90!&$SHV)P 4 'F2n[ %$5<YYX9$ \=!\ %\$5)\0\!5\L 0-\ a$\$(%$5u_l@e>$ $\\&70$0k3\+$ % )P$3?\ r\n?\$%\+\$#<y9& \ %\$5)\0<YY`9\! +0K$= )P\(%\$5\4!Z\3u\+!\ 0YYW6\0?\!{ #\0\!&$$ % \$0 %-$)0K$= ($2+ D!%$% 0[00/'/g 0\ ESL?\\!&$0 '\c)$\$0%\$70$u.$) J0'/g?$$"$$%L@ 70&&$"8D70$?$u.$ \\+'\/g?\$0?n-- 0\n\"\$70\\=!\ %\-$ $\^\0\[E$0u+! '\n%\)$\\0$?$%5$#$%l@ \"8 %@TXd60R${ & \$&0)$= 70$I& %!O \K$\= \3L$$ %@ #<WY907&$&&$ %@ \"x\%+rn?$$c(xj$ Will t al 2004.,Thamson t 9'n$J0 I A <al 2008., Zhao t al 2008 6$\"\?G\?=\$\&\S$?\$L?\\G?\"~?\"?G\S\K?!{ )$L 0 \\E\"%"0E0" ]\L#\@$\^70$08?$)0 5= $@%E-"=+?$ \ \$$\ \R70\$)0\0\n \\6\! \ $-$$\@7\4= <W9&?=\$\ A\\ %8"F \8>V\\ %@)0?G 0K$\\= )\\"G<9)$\\40K$\\= J0"<T9YY600$0<9lJ$ $#\$7\&70$0)\+\$%! 0'n$ I!\O\$?\"LG%\\"(J0 6\0v$\$'\/g0?= 6=!LL 0*\+$%\/g0)$40&YY YYXYYT4\0$P7\n'$$ E$0)\"$u+!Z3 %)0

!5< X ( <% ]\\!)$\\!%\\$) 'F\\2n\\[%\\/g E\870 g)$$0( a\&$@\5$$$('f2n!% #0$005E % (2!,3?"$%"?~"E$%?$?n?$ %!- '=$%t$e /$0^=+0I $L$K -O # 7 \+$$ % )P\(%\$5\0\ #<90 SHVE\\ %\.(%/g?$0 \[0\"$\/5\7\\\8 \$?\$#\&N$-\@)$\$0\?$$&O )\0\O\ )PN"@7! + \[%8$E$0)"$0Z3 p \[r\[$)\"$%@0 a?$6$#& )-L$a&M)"$$qR]!)$!/&O \ A\\ \)0"=&E %?$$q#& $)"$00>$_^/3$ HE8?FG Laboratory Standards Extndd-Spctrum - Lactamas Dtction Mthods. Journal of Clinical Microbiology, Amrican Socity for Microbiology8(39) p. 2864 2872 7- Xavir Will F., Dmartin M., TandD., Espi E., Rakotoarivony I., 2004. SHV-12- Lik Extndd-Spctrum--Lactamas- Producing Strains of Salmonlla ntrica Srotyps ablsbrg and Entritidis Isolatd In Franc among Infants Adoptd from Mali. Amrican Socity for Microbiology.,Journal Of Clinical Microbiology. 6(42) p. 2432 2437 8- Tasli H., Hakki I. Molcular charactrization of TEM and SHV drivd ESL in hospital basd Entrobactriaca in Turky. Jpn J Infct Dis.2005 58 162-167 $ #) 0$4& 8$ #b R${ & sw bla CTX F )P=k3+#)D % $ 7&$5!$ %-$ 0 bla TEM %> #)$4 _3! ) 0! TXX 4 #)$$ =&-O!& H= swkct6 #Z$$a@70$& sy 7!! %$$L!$= 8^$K3)$0Zg$] F %> #<TXdsXf9$& ) 7h 1- Ranjbar R., Giammanco G.M., Alo A., Anna Plano M.R., Naghoni A., and Mammina C., 2010. Charactrization of th First Extndd-Spctrum -Lactamas Producing Nontyphoidal SalmonllaStrains Isolatd in Thran, Iran. Food born Pathogns and Disas 7 p. 1-10 2- Rotimi V O., Jamal W., 2008. Emrgnc of multidrug-rsistant Salmonlla spp. and isolats with rducd suscptibility to ciprofloxacin in Kuwait and th Unitd Arab Emirats. Diagnostic microbiology and infctions disas 6071-77 3- Joklik J., Zinssr., Wolfgang K. Zinssr Microbiology- 20th Edition V. 2, systmatic bactriology, chaptr 15 P.269 4- Jmima S.A., Vrghs S., 2008. Multiplx PCR for blactx-m & blashv in th xtndd spctrum btalactamas (ESL) producing Gram-ngativ isolats, Indian J Md Rs 128 p. 313-317 5- Prz F., Endimiani A., Hujr K. M. and onomo R.A., 2007.Th Continuing Challng of ESLS. Amrican Curr Opin Pharmacol 7(5) 459 469. 6- Stward C.D., Rashd J. K., Hubrt S. K., iddl J. W., Rany P. M., Andrson G. J., Williams P. P., rittain K. L., 2001. Charactrization of Clinical Isolats of Klbsilla pnumonia From 19 Laboratoris Using th National Committ for Clinical

U"""!! ($ $ 0$ 7J+$0 TXW >+$0 % )O 6&)$4 18- Hamidian M., Tajbakhsh M., Rusmussn J.W., 2009. Emrgnc of Extndd-Spctrum -Lactamass in clinical Isolats of Salmonlla ntric in Thhran, Iran. Journal of Infction Disass 62 p. 368-371 19- D Ghldr Y., Avsani V., rhim C., Dlm M., Glupczynski Y. 2003. Evaluation of oxoid combination discs for dtction of xtndd-spctrum -lactamass.jac 52(4)591-597. 20- Chiartto G., Zavagnin P., ttini F., Mancin M., Minorllo C. 2008. Extndd spctrum -lactamas SHV-12-producing Salmonlla from poultry.vtrinary Microbiology 128 p. 406 413 21- Ahmd A. M., Younis E. A., Shimamoto T. 2009.Gntic basis of multidrug rsistanc in Salmonlla ntrica srovars Entritidis and Typhimurium isolatd from diarrhic calvs in Egypt, Acta Tropica 111 p. 144 149 22- Hasman H., Mvius D., Vldman K. 2005 -Lactamass among xtndd-spctrum - lactamas (ESL)-rsistant Salmonlla from poultry, poultry products and human patints in Th Nthrlands, Journal of Antimicrobial Chmothrapy 56 p.115 121 23- Wldhagn G. F., Poirl L. and Nordmann P., 2003. Amblr Class A Extndd-Spctrum -Lactamass in Psudomonas aruginosa Novl Dvlopmnts and Clinical Impact. MiniRviw. Amrican Socity for Microbiology. Antimicrobial AgntS and Chmothrapy. 47(8) p. 2385 2392 24- Zhao S.,Whit D.G.,Fridman S.L.,Glnn A., licknstaff K., Ayrs S.L.,Abbott J.W., Hall rabinson E., McDrmott P.F., 2008. Antimicrobial rsistac in salmonlla ntric srovar Hidlbrg isolats from rtail mays including poultry from 2002 to 2006. AEM.74(21) p.6656-6662. U6TXW )"?-^ =&-O E 7J+$0 Ufs`Ukc7& 11- Eftkhar F., Hossini-Mazinani S.M.2005. PCR dtction of plasmid mdiatd TEM, SHV and AmpC -lactamass in community and nosocomial urinary isolats of Eschrichia coli. Iranian Journal of iotchnology.vol. 3, No. 1, p.48-54 12- Thomson.K.S, lack.j,smith Moland.E, 2008. Idntification of plasmid-mdiatd xtndd-spctrum -lactamas CTX-M-57 in salmonlla ntric srovar Typhimorium.Intrnational Journal of Antimicrobial agnts.3176-90. 13- Douadi., Lin Thong K., Watanab H. Charactrization of Drug-Rsistant Salmonlla ntrica Srotyp Typhimurium by Antibiograms, Plasmids, Intgrons, Rsistanc Gns, and PFGE. J. Microbiol. iotchnol. 2010 20(6) 1042 1052 14- Morshd R., Pighambari S. M., 2010. Drug rsistanc plasmid profil and random amplifid polymorphic DNA analysis of Iranian isolats of salmonlla Entritidis.Nw Microbiologica.3347-56. 15- Zhao S., Qaiyumi S., Fridman S., Singh R., Foly S.L., McDrmott P.F., Donkar T., olin,3 S. Munro C., 2003. Charactrization of Salmonlla ntrica Srotyp Nwport Isolatd from Humans and Food Animals. Amrican Socity for Microbiology, Antimicrobial Agnts And Chmothrapy 12(42) p. 5366 5371 16- Aarstrup F. M., Hasman H., Vldman K., Mvius D. 2010. Evaluation of Eight Diffrnt Cphalosporins for Dtction of Cphalosporin Rsistanc in Salmonlla ntrica and Eschrichia coli. Microbial Drug Rsistanc 4(16) p.253-261 #vj! 0$#a%"$ sf [ % 0 @0 a& #! %!& ) 'F2n